Pathogenicity of Blastocystis hominis, A Clinical Reevaluation
PDF
Cite
Share
Request
Original Investigation
VOLUME: 31 ISSUE: 3
P: 184 - 187
September 2007

Pathogenicity of Blastocystis hominis, A Clinical Reevaluation

Turkiye Parazitol Derg 2007;31(3):184-187
1. Süleyman Demirel Universitesi Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Isparta, Türkiye
No information available.
No information available
Received Date: 18.12.2006
Accepted Date: 28.05.2007
PDF
Cite
Share
Request

ABSTRACT

Blastocystis (B.) hominis was considered to be a member of normal intestinal flora in the past, but in recent years it has been accepted as a very controversial pathogenic protozoan. In this study, 52 individuals whose stool examination revealed B. hominis were evaluated for clinical symptoms. Metronidazole was administered for 2 weeks to the patients infected with B. hominis. After 2 weeks of treatment they were called for a follow-up stool examination. No other bacteriological and parasitological agents were found during stool examination of these patients. The frequency rate of intestinal symptoms was 88.4% in the B. hominis cases. Abdominal pain was the most frequent symptom (76.9%). Diarrhea and distention followed at a rate of 50.0% and 32.6%. Intestinal symptoms may be seen frequently together with the presence of B. hominis and this protozoan may be regarded as an intestinal pathogen, especially when other agents are eliminated.

Keywords:
Blastocystis hominis, symptoms, pathogenicity